Example: Heart Attack

Clinical Trials on Coronary Restenosis

Total 184 results

NCT02367495

Completed

Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES

Conditions: Coronary Restenosis
NCT04280029

Recruiting

SELUTION SLR™ 014 In-stent Restenosis

Conditions: Coronary Restenosis
NCT03667313

Recruiting

Treatment of In-Stent Restenosis 2 Study

Conditions: Coronary Restenosis
NCT03242096

Unknown status

Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon

Conditions: Coronary Restenosis
NCT01269242

Completed

The Effects of Bindarit in Preventing Stent Restenosis

Conditions: Coronary Restenosis
NCT02944890

Completed

Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis

Conditions: Coronary Restenosis
NCT02300454

Unknown status

Effect of Combination of Non-sLip Element Balloon (NSE) and druG-coated bAlloon (DCB) for In-steNT Restenosis Lesions

Conditions: Coronary Restenosis
NCT00882219

Completed

Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period

Conditions: Coronary Restenosis
NCT01967199

Terminated

Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis

Conditions: Coronary Restenosis
NCT02263313

Completed

EGO-COMBO Clinical End-point Extension Study Beyond 36 Months

Conditions: Coronary Restenosis
NCT00859183

Completed

Oral Sirolimus for In-Stent Restenosis

Conditions: Coronary Restenosis
NCT00752362

Completed

Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)

Conditions: Coronary Restenosis
NCT00589810

Completed

Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal

Conditions: Coronary Restenosis
NCT00287573

Completed

Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis

Conditions: Coronary Restenosis
NCT00409981

Completed

Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR II)

Conditions: Coronary Restenosis
NCT00124943

Completed

Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis

Conditions: Coronary Restenosis
NCT00106587

Completed

Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I)

Conditions: Coronary Restenosis
NCT00500279

Unknown status

Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial

Conditions: Angioplasty, Transluminal, Percutaneous Coronary; Coronary Restenosis
NCT00627900

Completed

Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents

Conditions: Coronary Artery Disease
NCT00412126

Completed

Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI

Conditions: Diabetes Mellitus; Coronary Restenosis
NCT03074305

Recruiting

DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold

Conditions: Coronary Artery Disease; Coronary Restenosis
NCT02474485

Suspended

Absorb BVS vs. Drug Coated Balloon for Treatment Of ISR

Conditions: Coronary Artery Disease; Coronary Restenosis
NCT03008772

Withdrawn

REWARDS- In-stent Restenosis

Conditions: In-Stent Coronary Artery Restenosis
NCT01651390

Completed

Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.

Conditions: Coronary Artery Disease; Coronary Restenosis
NCT01485068

Completed

Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in In-Stent Restenosis Lesions (DEBREST)

Conditions: In-stent Coronary Artery Restenosis